LianBio Sponsored ADR LIANY
0.06
0.00
0.00%
as of 25 Sep
- Market cap
- $34.2M
- P/E
- 0.0×
Follow LIANY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
1,466.00 | 74.19 | 17.03 | 13.24 | 26.48 | 44.45 | 12.96 | — |
Net Debt/EBITDA |
7.41 | 1.36 | 5.77 | 2.43 | 1.96 | 1.89 | 1.75 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.21% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.01 | 1.51 | 0.83 | 0.90 | 0.84 | 0.70 | 0.48 | — |
Capex/Depreciation |
— | 0.00 | (0.28) | (1.83) | (1.80) | (11.66) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 11.75% | 0.77% | 70.96% | (32.39%) | (135.72%) | 245.17% | 32.79% | — | |
| 11.63% | 0.73% | 66.19% | (29.56%) | (55.64%) | (86.40%) | (111.09%) | — | |
ROIC |
(7.12%) | (217.43%) | (450.47%) | 0.00% | (2,990.73%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
23.88% | 3.94% | 53.56% | (37.74%) | (50.80%) | (51.45%) | (60.13%) | — |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
0.05 | 0.03 | 2.40 | (0.94) | (4.79) | (8.22) | (0.11) | — |
Cash per Share |
0.09 | 0.48 | 5.26 | 2.80 | 11.14 | 21.11 | 0.40 | — |
Shareholders Equity per Share |
0.19 | 0.58 | 5.39 | 2.72 | 11.26 | (8.14) | 0.36 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.19 | 0.58 | 5.39 | 2.72 | 11.26 | (8.14) | 0.36 | — |
Free Cash Flow |
4.94 | 3.75 | 258.79 | (101.03) | (164.90) | (99.03) | (11.72) | — |
Working Capital |
20.51 | 62.87 | 577.44 | 289.16 | 384.56 | 270.52 | 40.00 | — |
Capital Expenditures |
— | — | (0.37) | (1.84) | (0.95) | (0.89) | — | — |
Net Current Asset Value |
20.51 | 62.87 | 576.70 | 286.46 | 360.64 | (100.61) | 39.65 | — |
| Other line items | ||||||||
Quick Ratio |
1,399.29 | 71.99 | 16.86 | 12.88 | 25.79 | 44.07 | 12.94 | — |
Depreciation/Fixed assets |
— | 0.00 | 0.63 | 0.32 | 0.28 | 0.09 | 0.00 | — |
Cash ROIC |
16.52% | 3.27% | 22.38% | (17.16%) | (21.52%) | (63.32%) | (14.76%) | — |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
0.05 | 0.03 | 2.40 | (0.92) | (4.77) | (8.14) | (0.11) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.02) | (0.03) | (0.07) | 0.00 | — |
Average Receivables |
10.17 | 25.03 | 20.84 | 3.91 | 13.02 | — | — | — |
Average Payables |
— | 2.09 | 2.74 | 2.34 | 3.78 | — | — | — |
Average Assets |
42.12 | 340.84 | 468.96 | 373.15 | 352.81 | 161.58 | 21.94 | — |
Average Common Equity |
41.69 | 322.03 | 437.42 | 340.49 | 144.63 | (56.94) | (74.33) | — |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates